A Case of Severe Cholestasis due to Hepatic AL Amyloidosis

Introduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and...

Full description

Bibliographic Details
Main Authors: Teresa Dias, Diana Ferreira, Hélder Moreira, Telma Nascimento, Arsénio Santos, Armando Carvalho
Format: Article
Language:English
Published: Karger Publishers 2019-02-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/496185
id doaj-5f2d49428cc54decb27a26ac246f01f4
record_format Article
spelling doaj-5f2d49428cc54decb27a26ac246f01f42020-11-25T03:56:17ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452387-19542019-02-011510.1159/000496185496185A Case of Severe Cholestasis due to Hepatic AL AmyloidosisTeresa DiasDiana FerreiraHélder MoreiraTelma NascimentoArsénio SantosArmando CarvalhoIntroduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and severe intrahepatic cholestasis as the primary manifestation of the disease is rare. Clinical Case: We report an unusual case of primary amyloidosis in a 71-year-old man, presenting with rapidly progressive cholestasis, associated with hepatomegaly. There are a few reported cases in the literature of cholestasis and acute liver failure as the first manifestations of AL amyloidosis. Conclusion: Infiltrative diseases, such as amyloidosis, must be considered when a patient presents with cholestatic hepatitis. A liver biopsy is essential for the diagnosis of amyloidosis when liver test abnormalities dominate the initial clinical presentation. Liver involvement in patients with amyloidosis is often an indicator of poor prognosis.https://www.karger.com/Article/FullText/496185CholestasisAmyloidosisLiverMyeloma
collection DOAJ
language English
format Article
sources DOAJ
author Teresa Dias
Diana Ferreira
Hélder Moreira
Telma Nascimento
Arsénio Santos
Armando Carvalho
spellingShingle Teresa Dias
Diana Ferreira
Hélder Moreira
Telma Nascimento
Arsénio Santos
Armando Carvalho
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
GE: Portuguese Journal of Gastroenterology
Cholestasis
Amyloidosis
Liver
Myeloma
author_facet Teresa Dias
Diana Ferreira
Hélder Moreira
Telma Nascimento
Arsénio Santos
Armando Carvalho
author_sort Teresa Dias
title A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
title_short A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
title_full A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
title_fullStr A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
title_full_unstemmed A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
title_sort case of severe cholestasis due to hepatic al amyloidosis
publisher Karger Publishers
series GE: Portuguese Journal of Gastroenterology
issn 2341-4545
2387-1954
publishDate 2019-02-01
description Introduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and severe intrahepatic cholestasis as the primary manifestation of the disease is rare. Clinical Case: We report an unusual case of primary amyloidosis in a 71-year-old man, presenting with rapidly progressive cholestasis, associated with hepatomegaly. There are a few reported cases in the literature of cholestasis and acute liver failure as the first manifestations of AL amyloidosis. Conclusion: Infiltrative diseases, such as amyloidosis, must be considered when a patient presents with cholestatic hepatitis. A liver biopsy is essential for the diagnosis of amyloidosis when liver test abnormalities dominate the initial clinical presentation. Liver involvement in patients with amyloidosis is often an indicator of poor prognosis.
topic Cholestasis
Amyloidosis
Liver
Myeloma
url https://www.karger.com/Article/FullText/496185
work_keys_str_mv AT teresadias acaseofseverecholestasisduetohepaticalamyloidosis
AT dianaferreira acaseofseverecholestasisduetohepaticalamyloidosis
AT heldermoreira acaseofseverecholestasisduetohepaticalamyloidosis
AT telmanascimento acaseofseverecholestasisduetohepaticalamyloidosis
AT arseniosantos acaseofseverecholestasisduetohepaticalamyloidosis
AT armandocarvalho acaseofseverecholestasisduetohepaticalamyloidosis
AT teresadias caseofseverecholestasisduetohepaticalamyloidosis
AT dianaferreira caseofseverecholestasisduetohepaticalamyloidosis
AT heldermoreira caseofseverecholestasisduetohepaticalamyloidosis
AT telmanascimento caseofseverecholestasisduetohepaticalamyloidosis
AT arseniosantos caseofseverecholestasisduetohepaticalamyloidosis
AT armandocarvalho caseofseverecholestasisduetohepaticalamyloidosis
_version_ 1724465893756370944